President Donald Trump’s freeze on U.S. foreign aid has temporarily suspended key anti-narcotics programs in Mexico, impacting efforts to curb the flow of fentanyl into the U.S. The freeze affects all programs under the State Department’s Bureau of International Narcotics and Law Enforcement (INL), which trains Mexican authorities to dismantle clandestine fentanyl labs and intercept precursor chemicals.
INL initiatives, including drug-detecting canines that helped seize millions of fentanyl pills in 2023, have been put on hold. Former State Department official Dafna H. Rand criticized the freeze, stating it weakens the U.S.'s ability to combat the fentanyl crisis, which has claimed over 450,000 American lives in the past decade.
The freeze follows Trump’s "America First" policy, halting billions in foreign assistance worldwide. Despite Secretary of State Marco Rubio issuing waivers for humanitarian aid, most programs remain in limbo. Some officials suggest exemptions for foreign anti-narcotics programs are being considered, though no decision has been made on INL’s Mexico projects.
Trump has pledged to destroy Mexican cartels and threatened 25% tariffs on Mexico if it fails to curb fentanyl trafficking and illegal immigration. He has also pushed for designating cartels as terrorist organizations, expanding U.S. authority to target them. U.S. military surveillance of Mexican cartels has increased, raising concerns that Trump’s approach is shifting from cooperation with Mexico to unilateral action.
During his campaign, Trump called for military operations against cartels, signaling a tougher stance. While the administration’s next steps remain uncertain, the suspension of INL programs has stalled critical efforts to combat fentanyl at its source, complicating U.S.-Mexico cooperation on drug enforcement.


Keir Starmer Faces Mounting Pressure as Labour MPs Demand Leadership Change
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Arcadia Mayor Eileen Wang Pleads Guilty in China Foreign Agent Case
Trump Administration Seeks Court Pause to Reinstate 10% Global Tariffs
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Netanyahu Signals Plan to End Reliance on U.S. Military Aid Within 10 Years
Trump to Visit China for Key U.S.-China Summit With Xi Jinping
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Malaysia Unveils Energy Security Plan Amid Iran Conflict and Rising Oil Costs
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
U.S. Army Soldier Charged in $400K Insider Betting Scheme on Maduro Capture
Trump-Xi Summit Sparks Renewed Hope for Americans Detained in China
Judge Rules Use of Military Lawyers in Civilian Prosecutions Is Lawful
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit
US Sanctions Target Iran Oil Network Supplying China Ahead of Trump-Xi Talks 



